Accordingly, FOSL1 regularly resulted negative in low grade papillary NMIBC (FOSL1high = 0/20; 0%), although flat carcinoma in situ showed strong and heterogeneous expression in a fraction of cases (n = 8/11; Figure 6M–P). The gene discussed is FOSL1; the disease is in situ carcinoma.